Urticaria affects 10% to 25% of the population at some point in their life (Henderson, Fleischer, & Feldman, 2000). It is characterized by short-lived swellings of the skin, mouth, and genitalia ...
In addition, treatment with dupilumab resulted in a 15.86-point reduction in urticaria activity (itch ... Individuals with CSU develop hives and/or angioedema, can experience intense itching ...
The mainstay of treatment for urticaria is oral antihistamines as they reduce itch, wheal duration and numbers. Management is better achieved by taking antihistamines daily, not just when the ...
Even when the cause of chronic hives can't be identified, however, there are treatments that can help control symptoms in both types of chronic urticaria (and some 20% of people with CSU also have ...
Dupixent significantly reduced itch and hive activity from baseline; 41% of patients achieved well-controlled disease statusConfirmatory data to support US regulatory resubmission by year-end; if ...
which causes sudden and debilitating hives and persistent itch. CSU is typically treated with H1 antihistamines, medicines that target H1 receptors on cells to control symptoms of urticaria. However, ...